Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease

Summary

Exa-cel gene therapy data published in NEJM for children with transfusion-dependent β-thalassemia and sickle cell disease, demonstrating clinical efficacy in treating these severe blood disorders.